# Clinical Study of FB1001 in Patients

> **NCT06506305** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 59 (estimated)

## Conditions studied

- Optic Neuropathy
- NAION - Non-Arteritic Ischemic Optic Neuropathy
- APAC - Acute Primary Angle Closure
- Glaucoma, Angle-Closure

## Interventions

- **DRUG:** FB1001

## Key facts

- **NCT ID:** NCT06506305
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-15
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2024-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06506305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06506305, "Clinical Study of FB1001 in Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06506305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*